Posted: 18 November 2026 - Paris, France
A 3-year postdoctoral position funded by La Ligue contre le Cancer is available in the Guermonprez lab at Institut Pasteur Paris. The project aims to develop innovative tissue engineering approaches to improve CAR T cell therapy for solid tumors using mRNA-Lipid Nanoparticle (LNP) technology. The successful candidate will design, produce, and evaluate mRNA therapeutics, formulate them into LNPs, and assess their efficacy in preclinical tumor models. The role requires experience in animal experimentation, a strong background in cancer immunology or T cell immunology, and an interest in preclinical cancer models. Bioinformatics skills are an asset. The lab offers a supportive environment for academic career development, including student supervision and collaboration with bioinformatic engineers.